PT-141 peptide is a synthetic melanocortin analog studied for sexual dysfunction. Learn what it is, how it works, dosing research, and safety.
PT-141 (bremelanotide) is a synthetic peptide that activates melanocortin receptors in the brain and is FDA-approved as Vyleesi for hypoactive sexual desire disorder (HSDD) in premenopausal women. It is a prescription medication given as a subcutaneous injection, not a supplement or a general libido booster. PT-141 is not approved for erectile dysfunction, for men, or for use without a diagnosis.
What PT-141 Is and How It Works
PT-141 is a cyclic heptapeptide, meaning a ring-shaped chain of seven amino acids modeled on alpha-melanocyte-stimulating hormone. Chemists altered the natural hormone so it would bind melanocortin receptors, mainly MC4R, more reliably.
Melanocortin receptors sit in the central nervous system and influence arousal pathways. PT-141 therefore works on the brain's role in desire rather than on blood flow to the genitals, which is how PDE5 inhibitors such as sildenafil work.
Drug databases list the same molecule under three names: PT-141, bremelanotide, and the brand name Vyleesi. Someone typing what is pt-141 with a hyphen is searching for the identical compound.
What Is PT-141 Peptide Used For?
The FDA-approved answer to what is pt 141 peptide used for centers on one diagnosis: acquired, generalized hypoactive sexual desire disorder in premenopausal women who find their low desire distressing.
Everything else is off-label or research-only. Commonly discussed uses include:
- Erectile dysfunction in men, sometimes studied alongside a PDE5 inhibitor
- Premature ejaculation and other male sexual complaints
- General desire enhancement in people with no diagnosis
- Laboratory research on melanocortin signaling, appetite, and reward
Online sellers tend to stretch what is pt 141 good for into claims about confidence, performance, and mood. No claim about confidence, performance, or mood has been reviewed or approved by the FDA.
Approved Forms, Compounded Products, and Legal Status
In the United States, bremelanotide is a prescription-only drug sold as a single-use auto-injector. Compounding pharmacies and peptide websites offer nasal sprays, vials, and topical creams labeled PT-141, but those products are not FDA-approved for human use.
| Feature | Approved bremelanotide (Vyleesi) | Compounded or research-grade PT-141 |
|---|---|---|
| Regulatory status | FDA-approved prescription drug | Not FDA-approved |
| Form | 1.75 mg auto-injector for subcutaneous use | Nasal spray, vial, cream, or capsule |
| Dose accuracy | Fixed and tested | Variable; purity not independently verified |
| Labeled purpose | HSDD in premenopausal women | Often labeled not for human consumption |
| Legal to sell as a supplement | No | No |
Purity is the practical issue with unapproved peptides. A vial may contain less peptide than advertised, degraded material, or an unrelated compound, and sterility is not guaranteed.
PT-141 cannot legally be sold as a dietary supplement in the United States. Products marked for research use only are intended for laboratory work, and buying them for personal injection falls outside that label.
How PT-141 Is Dosed and How Long It Lasts
The approved dose is 1.75 mg injected under the skin of the abdomen or thigh at least 45 minutes before anticipated sexual activity. The label permits one dose in any 24-hour period and a maximum of eight doses per month.
Reported timing in trials and user reports follows a similar pattern:
- Injection is given about 45 minutes before activity.
- Effects are usually noticed within 30 to 60 minutes.
- Most users report the effect fading within 2 to 4 hours.
Extra doses do not improve results. They mainly increase nausea, flushing, and blood pressure changes.
Side Effects and Safety
Nausea is the most frequently reported side effect, affecting roughly 40% of participants in clinical trials. Flushing, headache, vomiting, and injection-site reactions are also common.
Other safety points worth knowing:
- Bremelanotide can cause short-term rises in blood pressure and heart rate.
- Repeated use has been linked to focal hyperpigmentation, or dark patches on the skin and gums.
- The label advises against combining it with naltrexone-containing medications, which may reduce its effectiveness.
- People with uncontrolled hypertension or significant cardiovascular disease should not use it.
Anyone considering PT-141 should review medications and health history with a licensed clinician first. Sexual desire problems can also stem from hormonal, psychological, or medication-related causes that a prescription peptide will not resolve.
How PT-141 Compares With Other Peptides
PT-141 gets discussed on the same forums as growth hormone and cosmetic peptides, but the compounds do unrelated things. Anyone researching what is ipamorelin peptide or what is cjc 1295 peptide is looking at growth hormone secretagogues, not a melanocortin agonist.
A rough map of the categories:
- PT-141: a melanocortin receptor agonist studied for sexual desire.
- Ipamorelin and CJC-1295: growth hormone-releasing peptides.
- Semax: a synthetic peptide studied for cognitive and neurological effects.
- AHK-Cu: a copper-binding peptide used in topical skin and hair research.
- Retatrutide: an investigational multi-receptor drug for obesity and metabolic disease.
Stacking peptides from different classes based on anecdotal reports is risky, because none of those combinations has been tested for safety. Each compound has its own dosing, side effect profile, and legal status.
The practical takeaway is that PT-141 is a narrow, prescription-only treatment for one specific diagnosis, not a generic libido product. Anyone with concerns about sexual desire or function should talk with a healthcare professional about approved options and realistic expectations.
Frequently Asked Questions
Is PT-141 FDA-approved?
Yes. Bremelanotide, sold as Vyleesi, was FDA-approved in 2019 for hypoactive sexual desire disorder in premenopausal women. PT-141 is not approved for men, for postmenopausal women, or for general libido enhancement.
How long does PT-141 last?
Effects usually begin within 30 to 60 minutes of a subcutaneous injection and last roughly 2 to 4 hours. The label allows one dose every 24 hours and no more than eight doses per month.
Can you buy PT-141 online without a prescription?
No. Bremelanotide is prescription-only in the United States, and peptides sold online as research chemicals are not approved for human use. Purity, sterility, and actual peptide content are not guaranteed with those products.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.